All Columns articles – Page 86
-
Opinion
Letters: July 2007
From Ronald Bentley In his ’Bench Monkey’ column (Chemistry World, April 2007, p40) Dylan Stiles notes that the odour of benzylmercaptan, used by a colleague, stays with him long after he leaves the lab. In 1989, I worked with the many reports describing the war-time research on the chemistry of ...
-
Opinion
Blinkers for bad news
The Avandia controversy poses some tough questions about how to balance risks, says Derek Lowe
-
OpinionEditorial: Questioning the FDA
There will be mutterings of unrest in the corridors of the US Food and Drug Administration (FDA) this month
-
Opinion
Letters: June 2007
From Peter Plesch When in 1989 I was writing the paper entitled The relation between reduction potential and solvation energy for some aryl-methylium ions, (J. Chem. Soc. Perkin Trans. 2, 1989, 1139), I needed the ionisation potentials of the tri-4-X-phenylmethyl radicals, where X = Cl, H, and MeO, as these ...
-
Opinion
Talking nanotechnology with the public
Philip Ball discusses Europe's efforts to communicate innovations in nanotechnology to a wide audience
-
Opinion
Patented fundamentals
Derek Lowe sets the record straight about pharmaceutical patents on traditional medicines
-
Opinion
Letters: May 2007
From Peter Plesch I wish to challenge Ted Nield’s Comment piece (Chemistry World, March 2007, p38). As chair of the Association of British Science Writers, he should know better than to lump together science and technology. Science is about finding and developing ideas about Nature in the widest ...
-
Opinion
Editorial: Mining traditional Chinese medicines
China holds great opportunities, but their drug industry must clean up its act
-
Opinion
Controversial colloid chemistry
Philip Ball reflects on the long-running debate about how colloids stick together
-
Opinion
Reasons to be cheerful
After months of bleak news about faltering pipelines and redundancies, it's time to find reasons to be cheerful about the drug industry, says Derek Lowe.